Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick…
The Belgian company Imcyse has raised €35M in a Series B round to develop a…
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the…
The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the…
The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to…
Galapagos has released positive data from two phase III trials testing its flagship drug candidate,…
Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with…
A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results…
Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little…
Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement…